Partner with the East Coast’s Only Tumor Modeling Forum Uniting the Leading Oncology Biopharma Companies
The oncology R&D landscape is shifting rapidly as regulatory momentum and market growth drive the industry toward more predictive, human relevant tumor models. With the US oncology market set for explosive expansion and investment in next generation platforms accelerating, the need for partners who can help drug developers strengthen translational confidence has never been greater.
Recognized as the singular Tumor Models forum drawing the highest concentration of oncology innovators from leading East Coast pharma and biotech teams, the 14th Tumor Models Summit Boston offers an unrivalled platform to engage decision makers actively seeking new partners, showcase your technology, and position your brand at the forefront of model enabled translational strategy.
As the most-established industry-focused forum already collaborating with Hub Organoids, Xenostart, Biocytogen and more, we’re uniquely positioned to elevate your visibility and connect you with teams that matter. Let’s position your brand where it matters most: directly in front of your highest value oncology clients.
Why Should You Prioritize Partnering?
Meet New Clients Across the East Coast
Expand your East Coast oncology network by meeting face-to-face with engaged decision-making attendees actively seeking solutions to overcome their preclinical and translational modeling challenges.
Showcase Yourself as Biopharma’s Partner-of-Choice
Present your work through a speaking engagement and a poster, participate in a panel discussion or showcase your solutions in a bespoke exhibition booth to demonstrate your company's unique capabilities.
Centre Yourself in Biopharma Dealmaking
Position your brand in front of decision-makers and technical experts by showcasing your company logo on event materials including our website, brochure, and on-site signage.
Gain Unfiltered Market Intelligence from Your Target Audience
Stay ahead of industry trends by hearing directly from the leaders driving model selection and pipeline integration. Gain clear feedback and understand competitor priorities to refine your organization’s strategy and sharpen your competitive edge.
Key Services & Solutions
Our community of tumor modeling experts and senior decision makers are seeking service and solution providers with capabilities in the below areas but not limited to:
Optimizing patient-derived in vivo tumor models to empower efficacy and toxicology studies across novel modalities and indications
Developing and validating in vitro, complex in vitro, ex vivo and computational tumor models to advance early drug discovery through to assessing toxicity
Identifying and validating biomarkers to understand disease mechanisms and predict patients’ response to treatment with biomarker assays
Leveraging digital pathology & multi-omics tools to empower model selection, improve modeling techniques, identify underserved patient populations and predict effective treatment regimes
Analyzing deeper levels of disease complexity by implementing highly sensitive imaging technologies
If your expertise aligns with the above, then this meeting is an unmissable opportunity to position yourself alongside the leading voices in the field, elevate your solutions and services, and establish yourself as THE ‘go-to’ partner for biopharma for all things tumor modeling and preclinical oncology-related.
Hear What Our Past Sponsors Have to Say
This was my first time attending this conference and I found it very focused. The meeting agenda was clear and interesting. I especially enjoyed the speed networking program, which allowed me to get to know more attendees.
Senior Director, ChemPartner
As always a good meeting with nice conversations.
Senior Director, Scientific Engagement and Key Accounts, Certis Oncology
Brings together a diverse group of people from industry.
Chief Executive Officer, Hub Organoids (part of Millipore Sigma)
It is a good group to network with and discuss potential projects and deals at the ground/lab level.
Vice President of Global Sales, InSphero
Audience Composition
Attending Companies Include
Available Inventory
We offer a flexible range of sponsorship opportunities designed to help you demonstrate scientific leadership, engage decision-makers, and align your brand with the future of tumor modeling innovation; from high-visibility packages to bespoke activations.
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Marinela Sealey
Business Development Manager